Aster Capital Management’s Latigo Biotherapeutics LTGO Stock Holding History
Bought
Maintained
Sold
Other funds holding LTGO
Aster Capital Management's LTGO Position: Q3 2026 in Review
Aster Capital Management opened a new position in Latigo Biotherapeutics (LTGO) in Q3 2026: 8,709 shares worth $145K. The stake represents 0.05% of the portfolio and ranks #392 among its holdings.
58 funds tracked by Wall St. Rank hold LTGO as of Q3 2026.
- Aster Capital Management held 8,709 shares of Latigo Biotherapeutics worth $145K as of Q3 2026.
- Latigo Biotherapeutics was a new Aster Capital Management position in Q3 2026.
- Latigo Biotherapeutics made up 0.05% of Aster Capital Management's portfolio in Q3 2026, its #392 holding.
- 58 funds tracked by Wall St. Rank held Latigo Biotherapeutics as of Q3 2026.
Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.